AXL Is a Novel Predictive Factor and Therapeutic Target for Radioactive Iodine Refractory Thyroid Cancer

Papillary thyroid carcinomas (PTCs) have an excellent prognosis, but a fraction of them show aggressive behavior, becoming radioiodine (RAI)-resistant and/or metastatic. AXL (Anexelekto) is a tyrosine kinase receptor regulating viability, invasiveness and chemoresistance in various human cancers, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Collina, Francesca, La Sala, Lucia, Liotti, Federica, Prevete, Nella, La Mantia, Elvira, Chiofalo, Maria Grazia, Aquino, Gabriella, Arenare, Laura, Cantile, Monica, Liguori, Giuseppina, Di Gennaro, Francesca, Pezzullo, Luciano, Losito, Nunzia Simona, Vecchio, Giancarlo, Botti, Gerardo, Melillo, Rosa Marina, Franco, Renato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628138/
https://www.ncbi.nlm.nih.gov/pubmed/31181609
http://dx.doi.org/10.3390/cancers11060785

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628138/
https://www.ncbi.nlm.nih.gov/pubmed/31181609
http://dx.doi.org/10.3390/cancers11060785

Ejemplares similares